Skip to main content

Table 4 Prediction of variable in study for the risk of developing DR in T2DM patients by multiple regression analysis

From: Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population

Variables T2DM patients without DR (DNR) T2DM patients with DR t-statistics value (t) P value
N (%) N (%)
Age (mean ± SD) 55.64 ± 10.23 57.86 ± 8.67 0.29 0.776
Gender (Males vs Females) 58 (36.3%)/102 (63.8%) 36 (46.2%)/42 (53.8%) 1.13 0.262
BMI (mean ± SD) 34.08 ± 6.99 33.92 ± 6.53 −0.463 0.644
Creatinine level (micromole/lit) ± SD 69.30 ± 28.55 81.5 ± 45.27 1.82 0.070
Glycated hemoglobin (HbA1c) mean% ± SD 8.24 ± 1.72 8.82 ± 1.83 1.99 0.048
LDL(mmol/lit)mean ± SD 2.95 ± 0.94 2.68 ± 1.04 −2.22 0.028
Triglycerides (mmol/lit) mean ± SD 1.77 ± 1.23 1.62 ± 0.75 −1.07 0.286
Blood Urea Nitrogen (mmol/lit) mean ± SD 5.24 ± 2.54 6.97 ± 4.49 −0.944 0.347
Mean Glucose levels (mmole/lit) ± SD 10.55 ± 6.68 9.92 ± 4.23 −0.165 0.87
SLMAP rs17058639 C > T genotypes TT = 29 (18.1%) TT = 6 (7.7%) −2.15 0.033
CT = 71 (44.4%) CT = 30 (38.5%)
CC = 60 (37.5%) CC = 42 (53.8%)
SLMAP rs1043045 C > T CC = 31 (19.4%) CC = 9 (11.5%) 0.95 0.294
CT = 70 (43.8%) CT = 31 (39.7%)
TT = 59 (36.9%) TT = 38 (48.7%)
SLMAP rs1057719 A > G GG = 30 (18.8%) GG = 8 (10.3%) 0.10 0.319
AG = 71 (44.4%) AG = 32 (41.0%)
AA = 59 (36.9%) AA = 38 (48.7%)
  1. t= > +2 or < −2 depicts significance in data; significant values shown in bold.